Future challenges for the economic evaluation of healthcare John F. P. Bridges Commentary 17 September 2012 Pages: 317 - 321
Pharmacoeconomic analyses using discrete event simulation J. Jaime Caro Current Opinion 17 September 2012 Pages: 323 - 332
Review of the cost effectiveness of immunisation strategies for the control of epidemic meningococcal meningitis Mark A. MillerCathryn K. Shahab Leading Article 17 September 2012 Pages: 333 - 343
Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease Helen DollMarc Miravitlles Review Article 17 September 2012 Pages: 345 - 363
Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone Claes-Göran LöfdahlÅsa EricssonEmma Andreasson Original Research Article 17 September 2012 Pages: 365 - 375
Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany Peter K. SchädlichHenning ZeidlerEduard Huppertz Original Research Article 17 September 2012 Pages: 377 - 393
Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany Peter K. SchädlichHenning ZeidlerEduard Huppertz Original Research Article 17 September 2012 Pages: 395 - 420